COVID Raises Risk of Long-Term Brain Injury, Large U.S. Study Finds
Pandemic
Opportunity Announced for Additional Support With Infection Prevention & Control for Personal Care Homes
The Pennsylvania Department of Health (DOH) and the Department of Human Services (DHS) recently released an announcement to personal care homes (PCH) regarding an opportunity to pursue additional support with infection prevention and control, COVID-19 response readiness, and other infectious disease preparedness at no cost.
DOH, in partnership with APIC Consulting Services, has developed a specially-tailored Infection Control and Response (ICAR) tool to assist a limited number of Personal Care Homes through an on-site assessment and consultation, development of improvement action plans, and numerous options for follow-up support.
Please see the announcement for details about pursuing this opportunity. Funding for the program is limited, and access to these services will be on a first come, first served basis. This program is not available to Assisted Living Residences or Personal Care Homes in Philadelphia County.
Questions can be sent electronically.
Local Mental Health Agencies Experience Counselor Shortage: RCPA Member Community Counseling Center of Mercer County Featured
State of Black and Brown Mental Health — Webinar on October 25
COVID-19 Vaccine and Boosters Update From ODP
ODP Announcement 22-105 provides the most recent update to recommendations from the Centers for Disease Control (CDC) about details for COVID-19 vaccine and boosters. Release of this announcement will obsolete “ODPANN 22-046: COVID-19 Vaccine Booster Reminder.”
This updated guidance includes information on newly available booster vaccines, which are referred to as bivalent or updated vaccines. The guidance also discusses the availability of a newer primary vaccine called the Novavax COVID-19 vaccine. The CDC has updated information regarding the vaccination schedule for individuals based on age and provides considerations based on additional factors. Full information is available at the CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.
Increased Use of Telehealth for Opioid Use Disorder Services During COVID-19 Pandemic Associated With Reduced Risk of Overdose
ACCSES Matters — September 2, 2022
FDA Authorizes Moderna, Pfizer-BioNTech Omicron Booster Shots
Coronavirus Boosters Targeting Omicron Get FDA Blessing for Fall Push
Home Health Aide Shortage Critical: Workforce Has Not Kept Up With Demand in Crucial Industry
Prev